Hafeeda Kunhabdulla, Ram Manas, Ashok Kumar Shettihalli, Ch Ram Mohan Reddy, Mohammed S Mustak, Raghu Jetti, Riaz Abdulla, Divijendranatha Reddy Sirigiri, Deden Ramdan, Muhammad Imam Ammarullah
Background: Head and neck squamous cell carcinoma (HNSCC) is one of the major types of cancer, with 900,000 cases and over 400,000 deaths annually. It constitutes 3-4% of all cancers in Europe and western countries. As early diagnosis is the key to treating the disease, reliable biomarkers play an important role in the precision medicine of HNSCC. Despite treatments, the survival rate of cancer patients remains unchanged, and this is mainly due to the failure to detect the disease early. Thus, the objective of this study is to identify reliable biomarkers for head and neck cancers for better healthcare management...
March 19, 2024: ACS Omega